Testing a new light technology for cancer detection in IBD
Part of Digestive system clinical trials.
This trial compares two methods to spot pre-cancerous changes during routine colonoscopy in people with inflammatory bowel disease (IBD). One method uses a special light filter (TXI) and the other uses a blue dye spray (chromoendoscopy) to see if TXI works as well or better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Crohn's disease or ulcerative colitis affecting a large part of your colon for at least 8 years (or you have PSC with IBD).
- You are at least 16 years old and need a routine surveillance colonoscopy.
- You are not on blood thinners that can't be paused before the procedure.
- You have not had part of your colon removed before.
- You are not pregnant and are willing to give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new camera system that adds texture and color enhancement to the usual white light during a colonoscopy. It aims to see if this new view helps doctors spot signs of inflammation or early cancer more clearly in people with inflammatory bowel disease.
This study looks at a special camera and protein tests to see how well treatments for IBD are working in children. It may help doctors learn more about your disease and how to best treat it.
This trial tests a new infrared light treatment to see if it can reduce inflammation and symptoms in people with Crohn's disease. It's for those who have active disease despite current treatments or who are not on therapy.
This trial tests a new imaging technique that may help doctors see inflammation more clearly during colonoscopy in people with Crohn's disease or ulcerative colitis. The technique is called Texture and Color Enhancement Imaging (TXI).
This study compares different special camera techniques during colonoscopy to see which best finds early abnormal (pre-cancer) changes in people with long-term ulcerative colitis. It may help doctors improve how they screen and monitor your colon over time.
This trial compares two methods for examining the colon during surveillance colonoscopy in people with inflammatory bowel disease (IBD). One method uses a virtual dye and the other uses a real dye to help detect early signs of cancer. The goal is to see which approach works better and is more comfortable for patients.
Hear when a new IBD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.